Pay in 4 interest-free payments of $5.64 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
2021;10(7):R20012
The primary advantage is superior bioavailability
Product Details Active Ingredient : Bremelanotide (PT-141) Concentration : 20 mg per vial (lyophilized powder) Administration : Subcutaneous injection after reconstitution Volume : Reconstituted per provider instruction (typically 12 mL bacteriostatic water) Use : For clinical and research use under medical supervision Storage : Store lyophilized powder at 28C (3646F)
Antibacterial SAR must therefore integrate permeability and efflux considerations from the earliest stages of design
and c) irregular dietary patterns), reduced bioavailability (impairment of the intrinsic factor-mediated absorption pathway, often due to the widespread and prolonged use of proton pump inhibitors), and malabsorption syndromes
US$ 25.95
US$ 29.03
US$ 26.87
